- Accu-Chek® Guide Me glucose meter to be paired with BlueStar® in Japan, which is being jointly developed by Astellas and Welldoc - - Initiation of clinical trial planned for fiscal year 2023 - TOKYO and COLUMBIA, Md., March 28, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Astellas and Roche Diabetes Care Japan ink partnership agreement to develop and commercialize integrated diabetes self-management solution with BlueStar® )
Also on site :